Pfizer recently announced that it agreed to acquire Wyeth

Pfizer recently announced that it agreed to acquire Wyeth (located in Eastern Henrico and the City of Richmond), becoming the premier global biopharmaceutical company with the strongest assets, pipeline and capabilities within health care. The diversity, agility and scale of the combined company will enable them to more effectively address the health, wellness and unmet medical needs of patients around the world. The opportunities created by this combination are far greater than either Pfizer or Wyeth could achieve alone. The new company, which will be called Pfizer, will be a leader in human, animal and consumer health; primary and specialty care; and biologics as well as pharmaceuticals.

Importantly, this combination will support Pfizer's mission to apply innovative science to improve world health.

The Company has pledged to continue contributing meaningfully to the communities in which they operate and clear about what will not change: commitment to patients, customers, patient assistance programs and medical safety; and support for health care reform that expands coverage, improves quality and provides value to patients.

In the meantime, further information is available at Pfizer recently announced that it agreed to acquire Wyeth (located in Eastern Henrico and the City of Richmond), becoming the premier global biopharmaceutical company with the strongest assets, pipeline and capabilities within health care. The diversity, agility and scale of the combined company will enable them to more effectively address the health, wellness and unmet medical needs of patients around the world.

The opportunities created by this combination are far greater than either Pfizer or Wyeth could achieve alone. The new company, which will be called Pfizer, will be a leader in human, animal and consumer health; primary and specialty care; and biologics as well as pharmaceuticals.

Importantly, this combination will support Pfizer's mission to apply innovative science to improve world health.

The Company has pledged to continue contributing meaningfully to the communities in which they operate and clear about what will not change: commitment to patients, customers, patient assistance programs and medical safety; and support for health care reform that expands coverage, improves quality and provides value to patients.

In the meantime, further information is available at www.premierbiopharma.com http://www.premierbiopharma.com/